glp-1 news 2025 november 25 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits FDA bans compounded GLP-1 drugs

O futuro traz novas opes ainda mais potentes, com: Ao mais prolongada (injees mensais) Menores efeitos colaterais Via oral (comprimidos no lugar de injees) Preservao da massa muscular durante a perda de peso Composio personalizada (associao com outros hormnios) Algumas dessas drogas j em fase de testes incluem: Retatrutida (GLP-1 + GIP + glucagon) Cagri-Sema (semaglutida + amilina) Orforglipron (GLP-1 oral, sem necessidade de jejum) VK2735 e GZR18 (potentes em perda de peso) Qual a diferena entre os medicamentos

Male pattern baldness at the crown follows a recognizable pattern, from subtle hair thinning to a more obvious crown bald spot that may eventually merge with a receding hairline

See the details in our article about supplements for weight and appetite control

Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users

Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis

A study using normal-weight adults looked at the difference between consuming 150g/d of fructose or 150 g/day of glucose for four weeks